The MarketWatch News Department was not involved in the creation of this content. -- Pharmaceutical customers and patients to benefit from the combined design, development and manufacturing services ...

Philips Medisize, a Molex company and a contract developer and manufacturer for medtech and pharma companies, has agreed to buy Vectura from a subsidiary of Philip Morris. The acquisition is expected ...

Hudson, Wis.-based injection molder Phillips-Medisize will expand its drug delivery operations with the acquisition of Medicom Innovation Partner, the companies announced on June 1st. 1. Medicom is a ...

Phillips Medisize, a contract development and manufacturing organization serving medical device and pharma OEMs acquired by Molex in 2016, announced today that it has completed the acquisition of ...

Molex LLC, parent to medical supplier Phillips-Medisize LLC, has signed an agreement through its Molex Asia Holdings Ltd. affiliate to acquire Vectura Group Ltd. from Vectura Fertin Pharma Inc., a ...

STAMFORD, CT--(BUSINESS WIRE)-- Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. (PMI) (NYSE: PM), today announces the sale of its subsidiary Vectura Group Ltd. (Vectura) ...

In a major move, Vectura Fertin Pharma, Inc., an affiliate of Philip Morris International Inc. PM, announced the sale of Vectura Group Ltd. to Molex Asia Holdings Ltd. This decision comes amid ongoing ...

SAN DIEGO, CA / ACCESSWIRE / August 16, 2023 / Modular Medical, Inc. (Nasdaq:MODD), a development stage insulin delivery technology company seeking to launch the next generation of user-friendly and ...

The Wisconsin Technical College System (WTCS) and Chippewa Valley Technical College (CVTC) recently honored Phillips-Medisize Corporation for its commitment to technical college education. The WTCS ...

HUDSON — Phillips-Medisize Corporation recently celebrated the individuals participating in the company’s internship and rotational programs. During the event, they learned first-hand, from company ...

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biomediq, Catalyst Medtech, Edap, Johnson & Johnson Medtech, Karl Storz, Molex Asia Holdings, ...